These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17314999)

  • 41. [VALUE study underscores the importance of reaching goal blood pressure values for minimization of cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct; 93(44):1836. PubMed ID: 15559910
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
    Epstein M; Hollenberg NK
    Am J Hypertens; 2004 Jul; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
    [No Abstract]   [Full Text] [Related]  

  • 43. Evolutionary cost analysis of valsartan initiation among patients with hypertension: a time series approach.
    Sun P; Chang J; Zhang J; Kahler KH
    J Med Econ; 2012; 15(1):8-18. PubMed ID: 22011107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial).
    Majahalme SK; Baruch L; Aknay N; Goedel-Meinen L; Hofmann M; Hester A; Prescott MF; Feliciano N;
    Am J Cardiol; 2005 Feb; 95(4):529-32. PubMed ID: 15695147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study.
    Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T
    Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reaching the therapeutic goal in hypertension: results from the Canadian valsartan observational study. (Diovantage 4).
    Tardif JC; Curnew GP; Leclerc JM; Rehel B
    Can J Clin Pharmacol; 2008; 15(2):e177-87. PubMed ID: 18515919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Control of systolic blood pressure in the VALUE trial after 12 months].
    Schmieder RE; Handrock R;
    Dtsch Med Wochenschr; 2003 Mar; 128(10):485-6. PubMed ID: 12627338
    [No Abstract]   [Full Text] [Related]  

  • 48. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
    Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
    J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.
    Gupta AK; Dahlof B; Dobson J; Sever PS; Wedel H; Poulter NR;
    Diabetes Care; 2008 May; 31(5):982-8. PubMed ID: 18235048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up.
    Almgren T; Wilhelmsen L; Samuelsson O; Himmelmann A; Rosengren A; Andersson OK
    J Hypertens; 2007 Jun; 25(6):1311-7. PubMed ID: 17563546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The safety of valsartan: results of a postmarketing surveillance study on 12881 patients in England.
    Biswas PN; Wilton LV; Shakir SW
    J Hum Hypertens; 2002 Nov; 16(11):795-803. PubMed ID: 12444541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.
    Anand IS; Rector TS; Kuskowski M; Thomas S; Holwerda NJ; Cohn JN
    Circ Heart Fail; 2008 May; 1(1):34-42. PubMed ID: 19808268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood pressure control in patients initiating antihypertensive therapy.
    Weycker D; Edelsberg J; Vincze G; Levy DG; Kartashov A; Oster G
    Ann Pharmacother; 2008 Feb; 42(2):169-76. PubMed ID: 18182472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
    Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. VALUE study highlights the need for aggressive BP lowering in high-risk patients.
    Cardiovasc J S Afr; 2004; 15(4):191-2, 195. PubMed ID: 15322578
    [No Abstract]   [Full Text] [Related]  

  • 57. Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.
    Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B;
    Heart; 2008 Feb; 94(2):e4. PubMed ID: 17916665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies.
    Elliott WJ; Plauschinat CA; Skrepnek GH; Gause D
    J Am Board Fam Med; 2007; 20(1):72-80. PubMed ID: 17204738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex differences in effects of valsartan administration on cardiovascular outcomes in hypertensive patients: findings from the Jikei Heart Study.
    Yoshida H; Shimizu M; Ikewaki K; Taniguchi I; Tada N; Yoshimura M; Rosano G; Dahlöf B; Mochizuki S;
    J Hypertens; 2010 Jun; 28(6):1150-7. PubMed ID: 20467269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.